Long-term survival of ipilimumab-naive patients with advanced melanoma (MEL) treated with nivolumab (anti-programmed peath-1; Anti-PD-1; Bms-936558; Ono-4538) in a phase I trial Meeting Abstract
| Authors: | Hodi, S.; Sznol, M.; Kluger, H. M.; McDermott, D. F.; Carvajal, R. D.; Lawrence, D. P.; Topalian, S. L.; Atkins, M. B.; Powderly, J. D.; Sharfman, W. H.; Puzanov, I.; Smith, D. C.; Leming, P. D.; Lipson, E. J.; Taube, J. M.; Anders, R. A.; Horak, C. E.; Kollia, G.; Gupta, A.; Sosman, J. A. |
| Abstract Title: | Long-term survival of ipilimumab-naive patients with advanced melanoma (MEL) treated with nivolumab (anti-programmed peath-1; Anti-PD-1; Bms-936558; Ono-4538) in a phase I trial |
| Meeting Title: | COSA's 41st Annual Scientific Meeting |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 10 |
| Issue: | Suppl.8 |
| Meeting Dates: | 2014 Dec 2-4 |
| Meeting Location: | Melbourne, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2014-12-01 |
| Start Page: | 177 |
| Language: | English |
| ACCESSION: | WOS:000345350900306 |
| PROVIDER: | wos |
| PUBMED: | 25409571 |
| DOI: | 10.1111/ajco.12305 |
| Notes: | Meeting Abstract: 378 -- Source: Wos |
